Anti-M üllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study.

CONCLUSIONS: In this analysis, premenopausal patients showed a high rate of ovarian impairment reflected by low AMH-levels after chemotherapy. PMID: 28732324 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28732324?dopt=Abstract

Source: Breast - July 18, 2017 Category: Cancer & Oncology Authors: Trapp EK, Steidl J, Rack B, Kupka MS, Andergassen U, Jückstock J, Kurt A, Vilsmaier T, de Gregorio A, de Gregorio N, Tzschaschel M, Lato C, Polasik A, Tesch H, Schneeweiss A, Beckmann MW, Fasching PA, Janni W, Müller V Tags: Breast Source Type: research